Oral Anticoagulant Therapy and Risk of Admission to Long-Term Care in patients With Atrial Fibrillation : A Nationwide Cohort Study
Loading...
Access rights
openAccess
publishedVersion
URL
Journal Title
Journal ISSN
Volume Title
A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä
This publication is imported from Aalto University research portal.
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
Other link related to publication (opens in new window)
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
Other link related to publication (opens in new window)
Date
2023-10
Major/Subject
Mcode
Degree programme
Language
en
Pages
6
Series
Journal of the American Medical Directors Association, Volume 24, issue 10, pp. 1484-1489
Abstract
Objectives: The impact of oral anticoagulants (OACs) on the need of long-term care (LTC) in the aging and multimorbid population of patients with atrial fibrillation (AF) is unknown. We conducted a nationwide cohort study to evaluate the effect of OACs on the need of LTC. Design: Retrospective nationwide cohort study. Setting and Participants: The registry-based FinACAF cohort study covers all patients with incident AF from all levels of care in Finland from 2007 to 2018, as well as all their OAC purchases, LTC admissions, and information on previous home care acuity. Methods: Incidence rate ratios (IRRs) of LTC admission were calculated using Poisson regression models with a Lexis-type data structure based on 3 time scales: follow-up time from AF diagnosis, calendar year, and age. Results: We identified 188,752 patients (49.0% female; mean age 71.4 years; mean follow-up 3.6 years) with incident AF without prior LTC, of whom 143,534 (76.0 %) initiated OAC therapy and 11,775 (6.2 %) were admitted to LTC. OAC therapy was associated with lower rates of LTC admission (adjusted IRR 0.79, 95% CI 0.76-0.82). When compared to warfarin, direct oral anticoagulants (DOACs) were associated with lower LTC admission rate (adjusted IRR 0.69, 95% CI 0.61-0.79). No significant disparities were observed between different DOACs. Conclusions and Implications: OAC therapy, particularly with DOACs, is associated with a substantially lower risk of admission to LTC in patients with AF. Increasing guideline-based OAC coverage among patients with AF may prevent the need of LTC, lengthen survival at home, and potentially decrease health care costs.Description
Funding Information: Funding/Support: This work was supported by the Aarne Koskelo Foundation , The Finnish Foundation for Cardiovascular Research , and Helsinki and Uusimaa Hospital District Research Fund ( TYH2019309 ). Publisher Copyright: © 2023 The Authors
Keywords
anticoagulation, Atrial fibrillation, direct oral anticoagulants, long-term care, nursing homes
Other note
Citation
Teppo, K, Airaksinen, K E J, Halminen, O, Linna, M, Jaakkola, J, Haukka, J, Putaala, J, Mustonen, P, Langén, V L, Kinnunen, J, Hartikainen, J & Lehto, M 2023, ' Oral Anticoagulant Therapy and Risk of Admission to Long-Term Care in patients With Atrial Fibrillation : A Nationwide Cohort Study ', Journal of the American Medical Directors Association, vol. 24, no. 10, pp. 1484-1489 . https://doi.org/10.1016/j.jamda.2023.05.016